Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of Thoracentesis, Tunneled Pleural Catheter (Pleurx), and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants (NOAC).

NCT03535883 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03535883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of Thoracentesis, Tunneled Pleural Catheter (Pleurx), and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants (NOAC).
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
October 30, 2017
Completion date
January 1, 2020
Enrollment
590 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pleural effusion, thoracic effusion